Dabigatran "real-life" results suggest caution needed

New data from real-life experience of dabigatran for stroke prevention in AF shows that it is often used outside prescribing recommendations, and the risk of both thromboembolism and bleeding may be raised in patients switched from warfarin.
Source: theHeart.org - Category: Cardiology Source Type: news